Form 4: FMR LLC Reports Beneficial Ownership Changes in Bicara Therapeutics Following IPO

FMR LLC reports changes in beneficial ownership of Bicara Therapeutics common stock following the conversion of preferred shares in connection with the company's initial public offering.

Summary

• FMR LLC filed a Form 4 with the SEC on September 18, 2024, reporting changes in beneficial ownership of Bicara Therapeutics Inc. (BCAX) stock.
• The changes occurred on September 16, 2024, in connection with Bicara Therapeutics' initial public offering (IPO).
• Series Seed, B, and C Preferred Shares converted into common stock on a 1-for-1 basis.
• F-Prime Capital Partners Life Sciences Fund VII LP indirectly acquired 10,818 shares of common stock, resulting in a total of 10,818 shares beneficially owned.
• F-Prime Capital Partners Life Sciences Fund VII LP indirectly acquired 712,430 shares of common stock, resulting in a total of 723,248 shares beneficially owned.
• F-Prime Capital Partners Life Sciences Fund VII LP indirectly acquired 392,085 shares of common stock, resulting in a total of 1,115,333 shares beneficially owned.
• Abigail P. Johnson, Director, Chairman, and CEO of FMR LLC, may be deemed to form a controlling group with respect to FMR LLC.

Sentiment

Score: 7

Explanation: The document is a routine regulatory filing related to an IPO. It doesn't contain any particularly positive or negative information, but the completion of the IPO is generally a positive event for the company.

Industry Context

This filing is a standard procedure following an IPO, reflecting the changes in ownership structure as preferred shares convert to common stock. It provides transparency into the holdings of major shareholders like FMR LLC.

Comparison to Industry Standards

• Form 4 filings are a standard regulatory requirement for individuals and entities holding more than 10% of a company's shares, or who are officers or directors, ensuring transparency in the market.
• Similar filings are common after IPOs as pre-IPO investors convert their preferred shares into common stock, reflecting their updated ownership positions.

Stakeholder Impact

• Shareholders: The filing provides transparency regarding the ownership structure of the company post-IPO.
• Employees: No direct impact is apparent from this filing.
• Customers: No direct impact is apparent from this filing.
• Suppliers: No direct impact is apparent from this filing.
• Creditors: No direct impact is apparent from this filing.

Key Dates